medicine shortage
In scarce supply
New SSSI allows pharmacists to substitute different brands and strengths of estradiol patches due to scarcity With estradiol patches in serious shortage, new legislation allows pharmacists to supply different brand …
One ‘like’ can send medication viral
Social media platforms are creating headaches for regulators, with posts highlighting the effects of medications fueling surging demand for prescription products, pharmacist warns Medicines regulators are struggling to detect and …
‘Unexpected demand’ hits Mounjaro single-use vials
Supplies of single-use vials of diabetes and chronic weight management medication, Mounjaro, are set to be limited over the coming months Pharmaceutical company, Eli Lilly, is forecasting that supplies of …
Zactin Tabs shortage set to continue
TGA extends fluoxetine substitution instrument in response to ongoing manufacturing issues Supply shortages impacting Zactin Tabs (fluoxetine 20mg dispersible tablets) are expected to continue until 30 June 2024, the medication’s …
Vyvanse supply issues ease
Supply issues impacting ADHD medication Vyvanse are set to return to normal by the end of the month Takeda Pharmaceuticals Australia is reporting that shortages of Vyvanse (lisdexamfetamine dimesilate) are easing, …
Mixed news on Vyvanse shortage
There has been good, and bad, news about the ongoing shortage of the ADHD treatment The Therapeutic Goods Administration (TGA) has an update informing of mixed news about ongoing shortages …
Update on morphine
Approval granted for the supply of overseas-registered morphine oral liquid products and new supply arrangements following Ordine discontinuation The Therapeutic Goods Administration (TGA) has granted approval for the supply of …
Substitution arrangement for fluoxetine
Temporary approval granted for replacement oral fluoxetine product as shortage continues Due to the shortage of fluoxetine (brand name: Zactin Tablet), the Federal Department of Health has announced it has …
Further Vyvanse shortages forecast
Takeda Pharmaceuticals Australia warns that a fourth strength of its ADHD medication, Vyvanse, will be in short supply Worldwide shortages of Takeda’s Vyvanse (lisdexamfetamine dimesilate) products are expected to …
Shortage continues
TGA warns of continuing shortages of an arthritis treatment, but says the situation may be easing The Therapeutic Goods Administration (TGA) says there may be some light at the end …
Meds suppliers monitor wharf strike
Long-running pay dispute flares up again, putting medicine supplies at potential risk Medicines industry groups are closely following re-ignited threats of strike action at wharves around Australia in case it …
Paracetamol shortage reported in NZ
While a shortage of paracetamol due to manufacturing issues has been reported in New Zealand, the TGA says the same effect is unlikely to occur here in Australia New Zealand …